AptarGroup, Inc. (ATR)
NYSE: ATR · Real-Time Price · USD
153.31
+0.82 (0.54%)
At close: Jun 6, 2025, 4:00 PM
153.31
0.00 (0.00%)
After-hours: Jun 6, 2025, 4:20 PM EDT
AptarGroup Market Cap
AptarGroup has a market cap or net worth of $10.12 billion as of June 6, 2025. Its market cap has increased by 3.12% in one year.
Market Cap
10.12B
Enterprise Value
11.06B
1-Year Change
3.12%
Ranking
Category
Stock Price
$153.31
Market Cap Chart
Since December 1, 1998, AptarGroup's market cap has increased from $1.03B to $10.12B, an increase of 879.08%. That is a compound annual growth rate of 8.98%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 5, 2025 | 10.07B | -3.67% |
Dec 31, 2024 | 10.45B | 28.55% |
Dec 29, 2023 | 8.13B | 13.26% |
Dec 30, 2022 | 7.18B | -10.95% |
Dec 31, 2021 | 8.06B | -9.00% |
Dec 31, 2020 | 8.86B | 19.87% |
Dec 31, 2019 | 7.39B | 25.09% |
Dec 31, 2018 | 5.91B | 9.94% |
Dec 29, 2017 | 5.37B | 16.72% |
Dec 30, 2016 | 4.60B | 1.50% |
Dec 31, 2015 | 4.54B | 4.86% |
Dec 31, 2014 | 4.33B | -3.11% |
Dec 31, 2013 | 4.47B | 40.89% |
Dec 31, 2012 | 3.17B | -8.05% |
Dec 30, 2011 | 3.45B | 8.03% |
Dec 31, 2010 | 3.19B | 32.10% |
Dec 31, 2009 | 2.42B | 1.53% |
Dec 31, 2008 | 2.38B | -14.90% |
Dec 31, 2007 | 2.80B | 37.43% |
Dec 29, 2006 | 2.03B | 11.48% |
Dec 30, 2005 | 1.82B | -3.31% |
Dec 31, 2004 | 1.89B | 33.33% |
Dec 31, 2003 | 1.42B | 26.09% |
Dec 31, 2002 | 1.12B | -10.61% |
Dec 31, 2001 | 1.26B | 20.14% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 687.38B |
Johnson & Johnson | 369.72B |
AbbVie | 331.15B |
Novo Nordisk | 324.15B |
UnitedHealth Group | 268.37B |
Abbott Laboratories | 233.03B |
Novartis AG | 230.96B |
AstraZeneca | 225.55B |